国内精品国产三级国产在线专_欧美日韩在线播放一区二区_成人xxxx视频_欧美激情视频一区_色女人综合av_久久久亚洲影院_久久久久久九九_成人免费网站在线_日韩美女毛茸茸_狠狠干一区二区

Links
Contact Info.
  • Address:杭州下沙高教園2號大街928號
  • Zip:310018
  • Tel:0571-86843527
  • Fax:
  • Email:[email protected]
Current Location :> Home > News > Text
碩士研究生李培鑫等完成的研究論文被《International Journal of Biological Macromolecules》錄用!

由碩士研究生李培鑫等完成的研究論文“Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia”被《International Journal of Biological Macromolecules(IF=8.20)》錄用!祝賀!!

Abstract: Androgenetic alopecia (AGA) is a transracial and cross-gender disease worldwide with a higher prevalence among young individuals. Traditional oral or subcutaneous injections are often used to treat AGA, however, they may cause severe side-effects and therefore effective treatments for AGA are currently lacking. In this work, to treat AGA, we developed a composite paste system based on minoxidil (MXD)-loaded nanoparticles and valproic acid (VPA) with the assistance of roller-microneedles (MNs). The matrix of composite paste systems is carboxymethyl cellulose (CMC), hyaluronic acid (HA) and polyvinylpyrrolidone (PVP). The roller-MNs can create microchannels in the skin to enhance drug transdermal efficiency. With the combined effects of the stimulation hair follicle (HF) regrowth by upregulating Wnt/beta-catenin of VPA and the mechanical microchannels induced by roller-MNs, the as-prepared composite paste systems successfully boost perifollicular vascularization, and activate hair follicle stem cells, thereby inducing notably faster hair regeneration at a lower administration frequency on AGA mouse model compared with minoxidil. This approach offers several benefits, including the avoidance of efficacy loss due to the liver’s first-pass effect associated with oral drug, reduction in the risk of infection from subcutaneous injection, and significant decrease in the side effects of lower-dose MXD.